Inventor
SIVAKUMAR PALLAVUR V
US23 patents
⚠️ This page may combine multiple inventors who share the name “SIVAKUMAR PALLAVUR V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZYMOGENETICS INC
11 patentsUS7351689B2Apr 1, 2008
Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
ZYMOGENETICS INC68 citations98
US7276478B2Oct 2, 2007
Methods of treating autoimmune diseases using IL-21
ZYMOGENETICS INC51 citations96
US7135170B2Nov 14, 2006
Methods for treating viral infection using IL-28 and IL-29
ZYMOGENETICS INC97 citations96
US7537761B2May 26, 2009
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC18 citations92
US7393684B2Jul 1, 2008
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies
ZYMOGENETICS INC25 citations92
US7923539B2Apr 12, 2011
IL-21 antagonists
ZYMOGENETICS INC7 citations84
US9708390B2Jul 18, 2017
Compositions and methods for inhibiting PDGFRbeta and VEGF-A
ZYMOGENETICS INC7 citations82
US7592427B2Sep 22, 2009
Antibodies to IL-21 receptor
ZYMOGENETICS INC7 citations74
US7871616B2Jan 18, 2011
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC1 citations62
US8361954B2Jan 29, 2013
Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
ZYMOGENETICS INC0 citations52
US10005837B2Jun 26, 2018
B7 family member zB7H6 and related compositions and methods
ZYMOGENETICS INC0 citations51
SIVAKUMAR PALLAVUR V
4 patentsUS9441034B2Sep 13, 2016
Compositions and methods for inhibiting PDGFRβ and VEGF-A
SIVAKUMAR PALLAVUR V44 citations95
US9388241B2Jul 12, 2016
Anti-human IL-21 antibodies
SIVAKUMAR PALLAVUR V8 citations83
US8790643B2Jul 29, 2014
Methods for treating disease using an anti-IL-21 receptor antibody
SIVAKUMAR PALLAVUR V2 citations62
US8222374B2Jul 17, 2012
IL-21 antagonists
SIVAKUMAR PALLAVUR V3 citations62
KLUCHER KEVIN M
3 patentsUS8283448B2Oct 9, 2012
Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
KLUCHER KEVIN M5 citations71
US8816053B2Aug 26, 2014
Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
KLUCHER KEVIN M2 citations60
US8318147B2Nov 27, 2012
Use of IL-29 for treating a dengue virus infection
KLUCHER KEVIN M0 citations49
XU WENFENG
3 patentsUS8163286B2Apr 24, 2012
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
XU WENFENG2 citations61
US8124088B2Feb 28, 2012
Methods of treatment using anti-IL-22RA antibodies
XU WENFENG3 citations61
US8536309B2Sep 17, 2013
Methods of producing anti-IL-22RA antibodies
XU WENFENG0 citations51